Functional and mechanistic study of miR-148a-3p as a novel biomarker for type 2 diabetic peripheral neuropathy
miR-148a-3p serves as a diagnostic biomarker and therapeutic target for T2DM-DPN by ameliorating hyperglycemia-induced cellular damage through direct PTEN suppression and modulation of neurovascular pathways.
Authors
- Chaoqiang Liu
- Jake Y. Chen (ORCID: https://orcid.org/0000-0001-8829-7504)
- Guangfei Xu
- Lie Ma
Institutions
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- Wuhan Third Hospital (CN)
- Rongcheng City People's Hospital (CN)
- Chongqing Dazu District People's Hospital (CN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1080/01616412.2025.2571981
- Primary Topic
- Nerve injury and regeneration
- Type
- article
- Field-Weighted Citation Impact
- 0.00